Target intelligence / Profile preview

Cysteine-rich protein 1 pseudogene 3 (CRIP1P3)

Target
CRIP1P3
Molecular classification
Pseudogene, Non-coding RNA (potential functional family, not protein-coding), Other
01

Overview

Cysteine-rich protein 1 pseudogene 3 (CRIP1P3) is a processed pseudogene of the cysteine-rich protein 1 (CRIP1) gene. Pseudogenes are genomic sequences related to functional genes that have lost their protein-coding ability due to mutations or lack of regulatory sequences and are widely categorized as nonfunctional vestiges by default[2][4]. However, a subset of pseudogenes, especially when transcribed, may act as regulatory non-coding RNAs with biological significance, sometimes modulating their parental gene or participating in molecular networks through mechanisms such as microRNA sponging[2][4]. There is currently *no evidence* that CRIP1P3 produces a protein or directly participates in known biological pathways, nor is it a recognized drug or disease target. Its primary significance, if any, would be non-coding RNA-mediated regulation, which is a potential area of ongoing research but not established for this specific locus. CRIP1P3 is **not a therapeutic target**. It is an **unprocessed pseudogene** (non-functional for protein-coding), and currently, no drugs interact with it. The canonical abbreviation is **CRIP1P3**; full name is **cysteine-rich protein 1 pseudogene 3**. No data support direct disease involvement or biomarker status for this pseudogene—any regulatory role is unconfirmed and would be limited to RNA-level effects[2][4].

Other names
CRIP1P3cysteine-rich protein 1 (intestinal) pseudogene 3
02

Mechanism of action

null

03

Biological functions

May participate in post-transcriptional regulation as a competitive endogenous RNA (ceRNA), modulating the expression of related protein-coding genes by sequestering microRNAs[4]No confirmed protein function
04

Disease associations

Functional pseudogenes can be associated with disease through regulatory effects, but there is no direct evidence for specific disease involvement for CRIP1P3[2][4]Other (possible disease association is speculative for this pseudogene)

Beyond the preview

Go deeper on Cysteine-rich protein 1 pseudogene 3 (CRIP1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysteine-rich protein 1 pseudogene 3 (CRIP1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call